In the REDEFINE 2 phase 3a trial involving adults with obesity and diabetes, the use of cagrilintidesemaglutide resulted in a significantly lower body weight than placebo at 68 weeks. Full trial results Does this chart seem accurate? : r cagrilintide If youve been struggling with weight loss despite eating better and trying harder, the issue may not be willpower it may be signaling., In this video, I break down how Cagrilintide works, its Cagrilintide GRAM Peptides Novo Nordisk advances obesity candidate to late stage program after weight loss of less than 12%